Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholders as on record date (to be determined and specified ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr Lalchandani Labs Ltd's Board of Directors, at its meeting on December 15, 2025, approved raising of funds through a Rights Issue of equity shares (face value ₹10 each) for an amount not exceeding Rs 433.31 Lakhs (approximately ₹4.33 crore). The funds will be raised from the company's eligible equity shareholders as on a record date that is yet to be determined. Key terms of the issue such as the issue price, entitlement ratio, record date, and payment timeline will be decided by the Board in due course, subject to regulatory approvals under the SEBI ICDR Regulations.
Eligible shareholders will get an opportunity to subscribe to additional shares in proportion to their existing holdings, but may need to invest more capital to maintain their ownership stake. The dilution is relatively small in size, and final terms will shape the actual impact on share price.